Design, Synthesis, and Biological Evaluation of Imidazopyrazinone Derivatives as Antagonists of Inhibitor of Apoptosis Proteins (IAPs)
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Jisook | - |
dc.contributor.author | Bae, Inhwan | - |
dc.contributor.author | Song, Jiyoung | - |
dc.contributor.author | Kim, Younghoon | - |
dc.contributor.author | Ahn, Younggil | - |
dc.contributor.author | Park, Hyun-Ju | - |
dc.contributor.author | Kim, Ha Hyung | - |
dc.contributor.author | Kim, Dae Kyong | - |
dc.date.accessioned | 2021-10-26T06:40:14Z | - |
dc.date.available | 2021-10-26T06:40:14Z | - |
dc.date.issued | 2021-06 | - |
dc.identifier.issn | 0253-2964 | - |
dc.identifier.issn | 1229-5949 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50728 | - |
dc.description.abstract | Apoptosis inhibitor (IAP) proteins are overexpressed in many cancers and implicated in tumor growth, so the development of antagonist that disrupts with the binding of IAP to their partner protein is a promising therapeutic strategy. In an effort to increase cellular activity and improve favorable drug-like properties, we newly designed and synthesized monovalent analogues based on imidazopyrazinone structure of 9. Optimization of cellular potency led to the identification of 17, which showed increase of submicromolar activity (GI(50) = 234 nM) and caspase-3 activation (6.3-fold) in MDA-MB-231 breast cancer cells. These findings clearly show the potential for 17 as a promising monovalent antagonist for the development of an effective anticancer treatment. | - |
dc.format.extent | 5 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | WILEY-V C H VERLAG GMBH | - |
dc.title | Design, Synthesis, and Biological Evaluation of Imidazopyrazinone Derivatives as Antagonists of Inhibitor of Apoptosis Proteins (IAPs) | - |
dc.type | Article | - |
dc.identifier.doi | 10.1002/bkcs.12271 | - |
dc.identifier.bibliographicCitation | BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.42, no.6, pp 847 - 851 | - |
dc.identifier.kciid | ART002724578 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000639588700001 | - |
dc.identifier.scopusid | 2-s2.0-85104142059 | - |
dc.citation.endPage | 851 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 847 | - |
dc.citation.title | BULLETIN OF THE KOREAN CHEMICAL SOCIETY | - |
dc.citation.volume | 42 | - |
dc.type.docType | Article | - |
dc.publisher.location | 독일 | - |
dc.subject.keywordAuthor | Imidazopyrazinone | - |
dc.subject.keywordAuthor | Inhibitors of apoptosis proteins antagonist | - |
dc.subject.keywordAuthor | Second mitochondrial activator of caspases | - |
dc.subject.keywordAuthor | Apoptosis | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.